MedTrace Logo

Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy

NCT01665651 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-05-08

No results posted yet for this study

Summary

Patients with serious chronic renal insufficiency usually develop secondary osteoporosis or bone loss, especially those with chronic dialysis, and the degree of bone loss is corrected with decrease of renal function. In traditional Chinese medicine, kidney function is considered to dominate bone development and metabolism. Kidney Yin and Yang replenishment will help improve bone development and metabolism.

Conditions

  • Renal Insufficiency, Chronic
  • Renal Osteodystrophy

Interventions

DRUG

Yougui granules

Yougui granules is traditional Chinese patent medicine used to treatment patients with kidney Yang deficiency. Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

DRUG

Zuogui granules

Zuogui granules is traditional Chinese patent medicine used to treatment patients with kidney Yin deficiency. Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

DRUG

Yougui granules placebo

Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

DRUG

Zuogui granules placebo

Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

Sponsors & Collaborators

  • Huadong Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Anhui University of Chinese Medicine

    collaborator OTHER

  • Longhua Hospital

    collaborator OTHER

  • Bing Shu

    lead OTHER

Principal Investigators

  • Yongjun Wang, Doctor · Longhua hospital affiliated to Shanghai Uni of TCM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01665651 on ClinicalTrials.gov